Results 111 to 120 of about 213,347 (314)

Real‐World Usage and Outcomes of Different Siltuximab Dosing Frequency in Idiopathic Multicentric Castleman Disease

open access: yes
American Journal of Hematology, EarlyView.
Yoshito Nishimura   +4 more
wiley   +1 more source

Recent advances in the construction of humanized animal models and applications in translational medicine

open access: yesAnimal Models and Experimental Medicine, EarlyView.
Substantial advances have been achieved in the development of humanized mouse models, which have proven highly valuable in evaluating cancer immunotherapies and elucidating the mechanisms of infectious diseases. There is now a growing shift in research toward larger animal models—such as pigs—that offer greater physiological similarity to humans ...
Yanan Lyu, Yong‐Guang Yang, Zheng Hu
wiley   +1 more source

Clinical and Laboratory Analysis of Children Who Follow Up with Thrombocytopenia: A Retrospective Study

open access: yesGüncel Pediatri
Introduction: Platelets are cells that play an important role in the first phase of hemostasis, where the clot plug is formed. Disorders in the number or function of platelets can lead to bleeding.
Yasemin Denkboy Öngen, Birol Baytan
doaj   +1 more source

Unusual yet isolated oral manifestations of persistent thrombocytopenia A rare case report

open access: yes
s with platelet-mediated disorders often present clinical manifestations of bruising and bleeding. Although these changes are detected most frequently on the skin, the oral cavity also may exhibit signs of bleeding.
Amit Byatnal, Neha Mahajan, Shrinivas Koppal, A Ravikiran, Thriveni R, Parvathi Devi M K
core  

Ovarian teratoma: yet another cause of immune thrombocytopenia

open access: yes, 2018
Dalia Khalife,1 Joseph Nassif,1 Ali Khalil,1 Ghina Ghazeeri,1 Ali Taher2 1Department of Obstetrics and Gynecology, American University of Beirut Medical Center, Beirut, Lebanon; 2Department of Internal Medicine, American University of Beirut Medical ...
Nassif J   +4 more
core  

Ocorrência de trombocitopenia em pacientes em uso de heparina internados no Hospital da Universidade Federal de Santa Catarina [PDF]

open access: yes, 2004
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina. Curso de Medicina.
Carvalho, Adriana de Siqueira
core  

Prophylactic Enoxaparin Reduces Symptomatic Venous Thromboembolism Compared With No Chemoprophylaxis Within 95 Days After Knee Arthroscopy

open access: yesArthroscopy, EarlyView.
Purpose To investigate whether prophylactic use of low‐molecular‐weight heparin (enoxaparin) after knee arthroscopy reduces the incidence of symptomatic venous thromboembolism (VTE) compared with no postoperative pharmacological prophylaxis. Methods We conducted a population‐based cohort study using linked national insurance and hospital data from ...
Aylin Albrecht   +5 more
wiley   +1 more source

Neonatal thrombocytopenia.

open access: yes, 2008
Thrombocytopenia (platelets
Roberts, Irene, Murray, NA, Roberts, I
core   +1 more source

ANK1 and EPB41 Variants and the Risk of Steroid‐Induced Osteonecrosis

open access: yesArthritis &Rheumatology, EarlyView.
Objective Steroid‐induced osteonecrosis of the femoral head (SONFH) is a refractory skeletal disorder influenced by genetic and environmental factors. However, conclusive pathogenic genetic evidence remains elusive due to the limited exploration of rare damaging variants. In this study, we aimed to identify rare variants associated with SONFH.
Shengbao Chen   +21 more
wiley   +1 more source

A heparin-indukálta thrombocytopenia

open access: yes, 2013
A heparin készítményeket évtizedek óta széles körben alkalmazzák az orvosi gyakorlatban, szinte nélkülözhetetlenek, ha antikoaguláns terápiáról van szó. Évente betegek ezreinek életét mentik meg.
Szaniszló, Dóra Edina
core  

Home - About - Disclaimer - Privacy